Epilepsy Talk

Generics: Important Statement From The American Academy Of Neurology | December 19, 2025

The American Academy of Neurology reports:

“The AAN opposes generic substitution of anticonvulsant drugs for the treatment of epilepsy without the attending physician’s approval.

The FDA has allowed for significant differences between name-brand and generic drugs.

This variation can be highly problematic for patients with epilepsy.

Even minor differences in the composition of generic and name-brand anticonvulsant drugs for the treatment of epilepsy can result in breakthrough seizures.”

Please read this article. It’s from those who know best and truly have OUR interests at heart!

To subscribe to Epilepsy Talk and get the latest articles, simply go to the bottom box of the right column, enter your email address and click on “Follow”

Resource:

The New York Times

http://graphics8.nytimes.com/package…angenerics.pdf

Posted in Epilepsy, Medication Issues
Tags: , ,

Leave a Comment »

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

    About the author

    Phylis Feiner Johnson

    Phylis Feiner Johnson

    I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.

    View Full Profile →

    To receive Epilepsy Talk articles FREE, simply go to the bottom of the right column, enter your email address and click on "Follow"

    Join 3,108 other subscribers
    Follow Epilepsy Talk on WordPress.com